DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q4 2021

SEC EDGAR SourceSEC Filings

Top Holdings363 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3.7M$446.2M4.6%$52.98+112.35%
12 qtrssince 2019-Q1
Increased
65
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

9.1M$179.1M1.8%$13.66+40.48%
12 qtrssince 2019-Q1
Increased
52

CALIX INC

2.1M$164.2M1.7%$31.06+153.41%
6 qtrssince 2020-Q3
Increased
48

CRINETICS PHARMACEUTICALS IN

4.8M$136.2M1.4%$21.26+31.85%
7 qtrssince 2020-Q2
Increased
68

RELAY THERAPEUTICS INC

4M$123.9M1.3%$35.82-12.15%
6 qtrssince 2020-Q3
Increased
61
DAVADAVA
ADR

ENDAVA PLC

737,067$123.8M1.3%$70.56+133.77%
12 qtrssince 2019-Q1
Increased
57

AMBARELLA INC

587,594$119.2M1.2%$136.77+47.10%
4 qtrssince 2021-Q1
Increased
48

CHAMPION HOMES INC

1.5M$119.1M1.2%$55.01+42.19%
12 qtrssince 2019-Q1
Increased
58

BOOT BARN HLDGS INC

956,002$117.6M1.2%$69.91+79.03%
5 qtrssince 2020-Q4
Increased
53

SITIME CORP

382,917$112M1.1%$45.86+534.74%
9 qtrssince 2019-Q4
Increased
49

SPRINGWORKS THERAPEUTICS INC

1.8M$110.8M1.1%
10 qtrssince 2019-Q3
Increased
52

GRID DYNAMICS HLDGS INC

2.9M$110M1.1%$23.64+60.66%
8 qtrssince 2020-Q1
Increased
50

AXCELIS TECHNOLOGIES INC

1.5M$108.5M1.1%$51.78+41.18%
4 qtrssince 2021-Q1
Increased
66

CELSIUS HOLDINGS INC

1.4M$107.9M1.1%$11.65+110.33%
7 qtrssince 2020-Q2
Increased
51

CYTOKINETICS INC

2.3M$106.1M1.1%$12.27+271.69%
11 qtrssince 2019-Q2
Decreased
0

XENON PHARMACEUTICALS INC

3.1M$97.6M1.0%$23.60+35.57%
8 qtrssince 2020-Q1
Increased
68
HDBHDB
ADR

HDFC BANK LTD-ADR

1.5M$96.4M1.0%$28.03+8.01%
12 qtrssince 2019-Q1
Increased
57

Vicor Corporation

738,149$93.7M1.0%$98.42+28.09%
9 qtrssince 2019-Q4
Increased
55

MICRON TECHNOLOGY INC

927,846$86.4M0.9%$91.740.00%
1 qtr
New
58

Impinj, Inc.

964,642$85.6M0.9%$66.08+35.86%
4 qtrssince 2021-Q1
Increased
57
$9.8B
AUM
363
Positions
Q4 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
+18%Q3'20$4.9B+27%Q4'20$6.2B+10%Q1'21$6.8B+11%Q2'21$7.5B+12%Q3'21$8.4B+16%Q4'21$9.8B
Activity profile
$ moved · Q4'21
New24%Increased38%Decreased15%Exited23%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q16%1-4Q33%1-2Y14%2Y+37%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $9.8B across 363 positions as of Q4 2021. Top holdings: TSM (4.6%), IBN (1.8%), CALX (1.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q4 2021 Summary

Active quarter - 96 new positions, 110 exits, 136 increased. Top move: CRNX (INCREASED, conviction 68). Portfolio: $9.8B across 363 positions.

Top holdings by portfolio weight

Total AUM$10B
TSM4.55%
IBN1.83%
CALX1.68%
CRNX1.39%
RLAY1.26%
DAVA1.26%
AMBA1.22%
SKY1.22%
BOOT1.20%
SITM1.14%
Other1.13%

Portfolio allocation by GICS sector

Sectors11
Technology25.56%
Unknown15.01%
Healthcare14.63%
Consumer Cyclical14.08%
Industrials10.22%
Financial Services8.08%
Basic Materials3.42%
Communication Services2.97%
Energy2.77%
Consumer Defensive2.64%
Other0.62%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Technology, Unknown, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used